Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 4/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | WDR5 | P61964 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6750355 | 0.90 | HDAC6 (0.36) | HDAC6THRBTP53MAPTHDAC1 | |
| SCHEMBL6749757 | 0.81 | HDAC6 (0.41) | HDAC6THRBHDAC1HDAC3HDAC8 | |
| SCHEMBL6745797 | 0.81 | HDAC6 (0.41) | HDAC6HDAC1HDAC3 | |
| SCHEMBL6749035 | 0.79 | HTT (0.44) | HDAC6MAPT | |
| SCHEMBL8319285 | 0.79 | HDAC6 (0.41) | HDAC6TP53MAPTHDAC1HDAC3 | |
| SCHEMBL6749379 | 0.78 | HDAC6 (0.37) | HDAC6 | |
| SCHEMBL6750238 | 0.78 | HDAC6 (0.42) | HDAC6TP53MAPTHDAC1HDAC3 | |
| SCHEMBL6745707 | 0.78 | HDAC6 (0.39) | HDAC6HDAC1HDAC3 | |
| SCHEMBL6749078 | 0.78 | HDAC6 (0.37) | HDAC6THRBHDAC1HDAC3 | |
| SCHEMBL6749663 | 0.77 | HDAC6 (0.39) | HDAC6HDAC1HDAC3HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | EISAI CO., LTD. | 2004-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092737-A1 | Benzopiperidine derivatives | HLA-DRB1, HRH1, HRH2 | HDAC6 1953/4885THRB 4064/4885TP53 550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.